Are We Closer to Free Market Eugenics? The Crispr Controversy
Might the 2018 birth of two designer babies in China write the opening paragraph for the next chapter in the history of eugenics? The worldwide scientific community has tacitly put a moratorium on human clinical application of CRISPR gene editing, waiting until unknown risks can become known. But th...
| Autor principal: | |
|---|---|
| Tipo de documento: | Electrónico Artículo |
| Lenguaje: | Inglés |
| Verificar disponibilidad: | HBZ Gateway |
| Journals Online & Print: | Gargar...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Publicado: |
Wiley-Blackwell
[2019]
|
| En: |
Zygon
Año: 2019, Volumen: 54, Número: 1, Páginas: 7-13 |
| (Cadenas de) Palabra clave estándar: | B
Método CRISPR/Cas
/ Eugénica
|
| Otras palabras clave: | B
CRISPR
B Ethics B Therapy B Bioethics B gene editing B Mejoramiento humano |
| Acceso en línea: |
Volltext (Resolving-System) Volltext (doi) |
| Sumario: | Might the 2018 birth of two designer babies in China write the opening paragraph for the next chapter in the history of eugenics? The worldwide scientific community has tacitly put a moratorium on human clinical application of CRISPR gene editing, waiting until unknown risks can become known. But this ethical agreement has been breached, and calls are now being heard for more rigorous regulations. Perhaps religious and spiritual leaders can join the bioethical chant: the yellow light of caution is flashing. |
|---|---|
| ISSN: | 1467-9744 |
| Obras secundarias: | Enthalten in: Zygon
|
| Persistent identifiers: | DOI: 10.1111/zygo.12501 |